Top Markets
#1 IQ IQ +17.57%
#2 Irys Irys +8.78%
#3 Bedrock Bedrock +8.20%
#4 パンチ (Punch) パンチ (Punch) +8.05%
#5 peaq peaq +6.86%
#6 Prom Prom +6.62%
#7 Reactive Network Reactive Network +5.87%
#8 Jito Jito +5.49%
#9 Wrapped Aave Base GHO Wrapped Aave Base GHO +4.96%
#10 Ridges AI Ridges AI +4.56%
Coin of the day
IQ IQ
Settings
Language
ENGLISH
Currency
USD
Theme
Medtronic plc Medtronic plc

Medtronic plc

2M6
Rank in Stocks #167
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Share Price
$88.76
Market Cap
$113.96B
Change (1 day)
-0.15%
Change (1 year)
-1.87%
Country
IE
Trade Medtronic plc (2M6)

Category

Healthcare
P/E ratio for Medtronic plc (2M6)
P/E ratio as of 2026 TTM: 0
According to Medtronic plc latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Medtronic plc from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 28.93 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 39.68 -
US
Medtronic Medtronic
Medtronic
MDT.US
 24.21 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 35.47 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SMMNY.US
 20.43 -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.